SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-039816
Filing Date
2021-06-11
Accepted
2021-06-11 16:12:19
Documents
2
Period of Report
2021-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1648
2 EX-24 DOCUMENT attachment1.htm EX-24 4290
  Complete submission text file 0001209191-21-039816.txt   7329
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459
Business Address
Cheng Sohanya Roshan (Reporting) CIK: 0001865796 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36167 | Film No.: 211011402